Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Biography
Amlan Chakraborty is from Amity Institute of Biotechnology, Amity University, Noida UP, India. Amlan Chakraborty has published research work on Natural Versus Synthetic Inhibition of the PI3K Pathway Causing Over-Expression and Reduced Apoptosis to HER2 Leading to ER+/HER2+ Breast Cancer.
Research Interest
Applied Bioinformatics & Computational Biology.
Publications
-
Exploring the Frontiers of Drug Discovery: Unveiling New Avenues for Therapeutic Advancement
Commentary:
DOI:
Antonio Lavecchia